Chet Rihal
Mayo Clinic
Internal medicineRadiologySurgeryCardiologyRandomized controlled trialClosure (topology)Mitral valve replacementAortic valve replacementArteryCardiogenic shockMitral valveRevascularizationHemolysisStenosisValve replacementRegurgitation (circulation)Percutaneous coronary interventionPercutaneousTranscatheter mitral valve repairCONGENITAL VALVULAR HEART DISEASEMitral regurgitationNational studyBypass graftingIn patientParavalvular leakTranscatheter aorticBalloon expandable stentIncidence (epidemiology)Myocardial infarctionMedicine
31Publications
3H-index
127Citations
Publications 30
Newest
#1Robert Avram (UCSF: University of California, San Francisco)H-Index: 7
#2Derek SoH-Index: 25
Last. Naveen L. Pereira (Mayo Clinic)H-Index: 36
view all 13 authors...
Source
#1Nahoko Kato (Mayo Clinic)H-Index: 3
#2Mayra Guerrero (Mayo Clinic)H-Index: 24
Last. Patricia A. Pellikka (Mayo Clinic)H-Index: 101
view all 11 authors...
Source
Source
Source
2 CitationsSource
Source
#1Didem Oguz (Mayo Clinic)H-Index: 3
#2Ratnasari Padang (Mayo Clinic)H-Index: 13
Last. Jeremy J. Thaden (Mayo Clinic)H-Index: 11
view all 11 authors...
Source
Source
Source
#1Raj Makkar (Cedars-Sinai Medical Center)H-Index: 89
#2William W. O'Neill (HFH: Henry Ford Hospital)H-Index: 63
Last. John G. Webb (St. Paul's Hospital)H-Index: 136
view all 8 authors...
Our aim was to determine the initial technical feasibility, clinical safety, and efficacy of the SAPIEN M3 System in patients with severe mitral regurgitation (MR). Mitral valve surgery is currently recommended in patients with severe, symptomatic MR. The SAPIEN M3 System is a novel, transvenous,
4 CitationsSource